An Investigational Study of Infliximab With Prednisone or Methylprednisolone Versus Prednisone Combination Treatment in Immune Related or Severe Diarrhea in Patients Treated With Yervoy and/or Opdivo
Clinical trial NCT02763761 · WITHDRAWN
Trial details
- NCT number
- NCT02763761
- Sponsor
- Bristol-Myers Squibb
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-16
- Primary completion
- 2017-03-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.